2m 2m 2m 2m 2m 2m 2m
VIRIDIAN THERAPT (VRDN)
NASDAQ
$19.00+$0.08 (+0.42%)
Price as of Aug 03, 2026 5:30 AM EDT- $2.1BMarket Cap
- 8.67%1-Year Change
- BiotechnologyIndustry
VIRIDIAN THERAPT (VRDN)
$19.00+$0.08 (+0.42%)
VRDN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $18.92 | ||
Change | -$0.98 (-4.92%) | ||
Open | $19.66 | ||
High | $19.90 | ||
Low | $18.89 | ||
Previous Close | $19.90 | ||
Volume | 1,088,052 | ||
30-Day Average Volume | 1,825,198 | ||
1-Week Change | -1.82% | ||
1-Month Change | 2.99% | ||
1-Year Change | 8.67% | ||
3-Year Change | 0.85% | ||
5-Year Change | 21.87% | ||
Fundamentals | |||
Shares Outstanding | 110.4M | ||
Total Assets | $789.0M | ||
Market Cap | $2.1B | ||
Enterprise Value | $2.0B | ||
Period: QTR TTM FY | |||
Revenue | $6,000.00 | ||
Net Income | -$104.9M | ||
Free Cash Flow | -$119.7M | ||
EBIT | -$104.9M | ||
EBITDA | -$104.8M | ||
Net Working Capital | $732.9M | ||
EPS | -$0.90 | ||
Enterprise Value/EBITDA | -19 | ||
Enterprise Value/Revenue | 333,246 | ||
P/B | 3 | ||
P/E | -21 | ||
PEG | -1 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 11/13/2020 | ||
Earnings & Revenue